Assessment of stent retrievers in acute ischaemic stroke

The Lancet

Volumn 380, Issue 9849, 2012, Pages 1208-1210

  Gorelick, Philip B ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

BRAIN BLOOD FLOW; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; DRUG EFFICACY; HUMAN; MORTALITY; NEUROIMAGING; NOTE; PATIENT SAFETY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECANALIZATION; REPERFUSION; STENT RETRIEVER; THROMBECTOMY; TREATMENT RESPONSE; VASCULAR STENT;

EID: 84867065405     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)61302-6     Document Type: Note

References (12)

1. Tomsick TA, Khati P, Jovin T, et al. Equipoise among recanalization strategies. Neurology 2010; 74: 1069-76.
2. Brinjikji W, Rabinstein AA, Kallmes DF, Cloft HJ. Patient outcomes with endovascular embolectomy therapy for acute ischemic stroke-a study of the National Inpatient Sample: 2006-2008. Stroke 2011; 42: 1648-52.
3. Baker WL, Colby JA, Tongbram V, et al. Neurothrombectomy devices for the treatment of acute ischemic stroke: state of the evidence. Ann Intern Med 2011; 154: 243-52.
4. Guyatt GH, Crowther M, Gutterman DD, Schunemann HJ, for the American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th edn: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: 7S-47S.
5. NINDS statement. Interventional management of stroke III trial. http://www.ninds.nih.gov/disorders/clinicaltrialsINCT00359424.htm (accessed June 3, 2012).
6. Albers GW, Goldstein LB, Hess DC, et al. Stroke treatment academic industry roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies. Stroke 2011; 42: 2645-50.
7. Balucani C, Grotta JC. Selecting stroke patients for intra-arterial therapy Neurology 2012; 78: 755-61.
8. Gorelick PB. How baseline severity affects efficacy and safety outcomes in acute ischemic stroke intervention trials. Ann NY Acad Sci (in press).
9. Saver JL, Jahan R, Levy EL, et al. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012; published online Aug 26. http://dx.doi.org/10.1016/S0140-6736(12)61384-1.
10. Nogueira RG, Lutsep HL, Gupta R, et al for the TREVO 2 Trialists. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet 2012; published online Aug 26. http://dx.doi.org/10.1016/S0140-6736(12)61299-9.
11. Schellinger PD, Kohrmann M. Current acute stroke trials and their potential impact on the therapeutic time window. Expert Rev Neurother 2012; 12: 169-77.
12. Parsons M, Spratt N, Bivard A, et al. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. N Engl J Med 2012; 366: 1099-107.